Evidence map›Paper›PMID 21633827›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2011

The calcium scare--what would Austin Bradford Hill have thought?

B E C Nordin, J R Lewis, R M Daly, J Horowitz, A Metcalfe, K Lange, R L Prince

Abstract read
PubMed Publisher
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2019
    Guideline
  3. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2013
    Guideline
  4. Review
  5. Are more trials of calcium supplements really needed?Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Article
  6. Article
  7. Article
  8. The predicted lifetime costs and health consequences of calcium and vitamin D supplementation for fracture prevention-the impact of cardiovascular effects.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Article
  9. Article
  10. Calcium supplement intake and risk of cardiovascular disease in women.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Article
  11. Clinical practice. Calcium supplements and fracture prevention.The New England journal of medicine · 2013
    Review
  12. Calcium supplements and cardiovascular risk: 5 years on.Therapeutic advances in drug safety · 2013
    Review
  13. Review
  14. The out-of-focus bias in drug surveillance.European journal of clinical pharmacology · 2013
    Article
  15. Article
  16. A review of calcium supplements and cardiovascular disease risk.Advances in nutrition (Bethesda, Md.) · 2012
    Review
  17. Re: The calcium scare: what would Austin Bradford Hill have thought?Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

B E C NordinEndocrine and Metabolic Unit, Royal Adelaide Hospital, North Terrace, Adelaide, SA, 5000, Australia. christopher.nordin@health.sa.gov.au
J R Lewis
R M Daly
J Horowitz
A Metcalfe
K Lange
R L Prince
University of Adelaide · AUDeakin University · AURoyal Adelaide Hospital · AUSir Charles Gairdner Hospital · AUUniversity of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledDetailed consideration of the suggested association between calcium supplementation and heart attacks has revealed weakness in the evidence which make the hypothesis highly implausible.

introductionThe aim of this study was to evaluate the strength of the evidence that calcium supplementation increases the risk of myocardial infarction.

methodsThis study used critical examination of a meta-analysis of the effects of calcium supplements on heart attacks in five prospective trials on 8,016 men and women, and consideration of related publications by the same author.

resultsThe meta-analysis was found to be subject to several limitations including non-adherence to the clinical protocol, multiple endpoint testing and failure to correctly adjust for endpoint ascertainment. The main risk factors for myocardial infarction were not available for 65% of the participants, and none of the trials had cardiovascular disease as its primary endpoint. There were more overweight participants, more subjects on thyroxine and more men on calcium than on placebo. In particular, over 65% of all the heart attacks were self-reported. When the evidence was considered in the light of Austin Bradford Hill's six main criteria for disease causation, it was found not to be biologically plausible or strong or to reflect a dose-response relationship or to be consistent or to reflect the relationship between the trends in calcium supplementation and heart attacks in the community or to have been confirmed by experiment. The addition of a more recent trial on 1,460 women over 5 years reduced the relative risk to 1.23 (P = 0.0695).

conclusionPresent evidence that calcium supplementation increases heart attacks is too weak to justify a change in prescribing habits.

Indexed as

Meta-Analysis as TopicAttitude of Health PersonnelCalcium, DietaryDietary SupplementsEvidence-Based MedicineFemaleHumansMaleMyocardial InfarctionRandomized Controlled Trials as TopicResearch DesignRisk FactorsCalcium, Dietary

Identifiers

PMID21633827
OpenAlexW2075499286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.